RING CHRISTINE (General Counsel) sold 37.5% of their position (8.15K shares) of NURIX THERAPEUTICS, INC. on the open market
Open‑market sale worth $135.3K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/2/2026ACC: 0001817199-26-000020
Officer· General Counsel
Since Jul 2020
-8.15K
Net shares
Net seller
$135.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.42K acquired · 11.57K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.42K
Price / share
$1.86
Trade value
$6.36K
% of position
18.7%
6/2/2026
18.30K→21.73K
Common Stock
Direct
Shares
−8.15K
Price / share
$16.60
Trade value
$135.25K
% of position
37.5%
6/2/2026
21.73K→13.58K
Total
Net shares
−4.73K
Net value
-$128.89K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/2/2026 | M · Option Exercise | +3.42K | $1.86 | $6.36K | 18.7% | 18.30K | 21.73K |
| Common Stock Direct | 6/2/2026 | S · Sale | −8.15K | $16.60 | $135.25K | 37.5% | 21.73K | 13.58K |
| Total | −4.73K | -$128.89K | ||||||
Derivative Transactions1
Employee Stock Option (right to buy)
Direct
Converts to
Common Stock
3.42K shares
Shares
−3.42K
Strike price
1.86
Held after
5.22K
Exercisable
—
6/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) Direct | Common Stock3.42K shares | 6/2/2026 | M · Option Exercise | −3.42K | 1.86 | — | 5.22K |